Article

Demographic differences in Down syndrome livebirths in the US from 1989 to 2006

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, CT 06030, USA.
Prenatal Diagnosis (Impact Factor: 3.27). 04/2011; 31(4):389-94. DOI: 10.1002/pd.2702
Source: PubMed

ABSTRACT

To explore demographic differences in Down syndrome livebirths in the United States.
Using National Center for Health Statistics (NCHS) birth certificate data from 1989 to 2006 we analyzed Down syndrome livebirths after correcting for under-reporting. We created six subsets based on maternal age (15-34 and 35-49 years old); US regions, that is, Northeast, Midwest, South and West; marital status, (married, unmarried); education, ( ≤ 12 years, ≥ 13 years); race, (white, black); and Hispanic ethnicity, (non-Hispanic, Hispanic). We estimated expected Down syndrome livebirths assuming no change in birth certificate reporting. The percentage of expected Down syndrome livebirths actually born was calculated by year.
There were 72 613 424 livebirths from 1989 to 2006. There were 122 519 Down syndrome livebirths expected and 65 492 were actually born. The Midwest had the most expected Down syndrome livebirths actually born (67.6%); the West was lowest (44.4%). More expected Down syndrome livebirths were born to women who were 15 to 34 years old (61 vs 43.8%) and to those with ≤ 12 years education (60.4 vs 46.9%), white race (56.6 vs 37%), unmarried (56.0 vs 52.5%), and of Hispanic ethnicity (55.0 vs 53.3%).
The percentage of expected Down syndrome livebirths actually born varies by demographics.

  • Source
    • "Currently, prenatal screening tests are widely offered by antenatal clinics to pregnant women over 35 years of age who are at greater risk. Despite the success of these screening programmes up to 61% of all infants with Down syndrome are born to women under the age of 35 who are not routinely offered testing [4]. By maternal serum screening, in combination with ultrasound assessment of nuchal translucency, approximately 90% of all Down syndrome pregnancies can be detected [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Non-invasive methods to assess the foetal genome during pregnancy will provide new opportunities to offer pregnant women a more comprehensive genetic diagnosis of their established foetus. The aim of this study was to determine the presence and frequency of foetal cells in transcervical cell (TCC) mucus samples from pregnant women and determine their suitability for early prenatal diagnosis. Methods: Syncytiotrophoblasts in aspirated TCC mucus samples were identified by immunostaining with the foetal-specific antibody NDOG1. Genetic analysis of foetal cells was performed by laser capture microdissection and quantitative fluorescent PCR (QF-PCR). Results: In 116 of 207 (56%) TCC samples, abundant syncytiotrophoblasts were retrieved. However, when TCC samples were stratified for the presence of chorionic villous fragments, syncytiotrophoblasts were identified in 85 of 109 (78%) samples. Significant numbers of syncytiotrophoblasts were found in TCC samples collected between 6 and 9weeks of gestation (mean 741, range 25-2884). QF-PCR analysis of NDOG1 positive syncytiotrophoblasts and matching maternal DNA confirmed their foetal origin and correct foetal cell sexing was achieved in 97% of TCC samples. The one discordant sex diagnosis was associated with a dizygotic dichorionic twin pregnancy resulting from the implantation of a female T21 embryo and a normal male embryo, where the female T21 foetus had succumbed at 6weeks of gestation and was vanishing. Conclusions: Syncytiotrophoblasts can be successfully isolated from TCC samples and represent a suitable source of cells for genetic analysis of the established foetus in early pregnancy. The study highlights a vanishing twin as a potential cause for discordant non-invasive prenatal test results.
    Full-text · Article · Sep 2014 · Clinica Chimica Acta
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Down syndrome is one of the most common conditions encountered in the genetics clinic. Due to improvements in healthcare, educational opportunities, and community inclusion over the past 30 years, the life expectancy and quality of life for individuals with Down syndrome have significantly improved. As prenatal screening and diagnostic techniques have become more enhanced and widely available, genetic counselors can expect to frequently provide information and support following a new diagnosis of Down syndrome. This guideline was written for genetic counselors and other healthcare providers regarding the communication of a diagnosis of Down syndrome to ensure that families are consistently given up-to-date and balanced information about the condition, delivered in a supportive and respectful manner.
    Full-text · Article · May 2011 · Journal of Genetic Counseling
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Down Syndrome (DS) is the most commonly identified genetic form of intellectual disability and is characterized by specific phenotypic disposition with set of congenital defects. Epidemiologic study of DS was initiated immediately after its discovery in mid 1800s and with the advent of karyotyping its etiology was identified. It is the triplication of human chromosome 21 (Ch21), that is the presence of an extra copy of Ch21, causes the typical phenotypic features of DS. The supernumerary Ch21 arises due to nondisjunction (NDJ) of the chromosome at anaphase of meiosis during parental gametogenesis. It is now estimated that nearly 95% of all live born DS have an extra copy of Ch21 due to meiotic NDJ, whereas other forms of DS namely, somatic mosaicism due to mitotic error in embryonic development and translocation of Ch21 account for the rest. For overwhelming majority of cases within the non disjoined category , 90% of the error arises in oocyte. It is probably the protracted phase of oogenesis that makes the women more susceptible to NDJ than their male partners. Detail epidemiologic and population based research have identified advanced maternal age and altered pattern of meiotic recombination as two risk factors that make the oocyte susceptible to acquire faulty number of chromosome. The birth prevalence study revealed a progressive increase in incidence of DS birth with advancing age of women and several hypotheses have been put forwarded to explain the maternal age effect on meiotic chromosome segregation system. STR(short tandem repeat) markers based genotyping of DS family demonstrated that ~80% of maternal errors occur in first phase of meiosis ,that is meiosis I (MI), and there is fall in usual recombination frequency on Ch21 that experience NDJ at MI. With chromosome mapping approach, workers have succeeded in
    Full-text · Chapter · Jun 2011
Show more